The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.

Sponsor
CorEvitas
Study ID
NCT06354101
Status
Withdrawn

Conditions

  • Metabolic Health

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Tirzepatide — DRUG
    Once-weekly subcutaneous injectable
  • Semaglutide — DRUG
    Once-weekly subcutaneous injectable

Study Details

The purpose of this registry study is to learn more about metabolic health. The information gathered will be used to support research on the natural history of obesity and weight related diseases, their treatments, and how it affects overall health. Approximately 15,000 participants who are overweight or have obesity with or without metabolic diseases are expected to participate in this registry study.

Key Dates

Start date
Jul 1, 2023
Status verified
Mar 2023
Primary completion
Jul 1, 2023
Completion
Jul 1, 2023

Study Design

Enrollment
0 participants (actual)

Primary Outcome Measure

Main Objective of Registry [ Time Frame: Up to 10 years ]

Related Studies